RxDoctor Payments Data

Charles Disabatino

Rheumatology · New Haven, CTNPI 1457337644

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,504 and has fallen 97.3% since, to $41 in 2021.

$1,788in general payments, 2019–2025

Across 104 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$254
  • Pfizer$231
  • Novartis$166
  • UCB, Inc.$165
  • Lilly USA, LLC$154
  • Genentech USA, Inc.$152
  • plus $666 from 12 others

What the payments were for

  • Food & beverage$1,787100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,788 in reported general payments places this provider in the 60th percentile of 118 rheumatology providers in Connecticut.

See all rheumatology providers in Connecticut

Other rheumatology in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →